Sandro Barni, Gerardo Rosati , Sara Lonardi et al. On behalf of TOSCA Investigators
Ther Adv Med Oncol 2020 Jan 20;12:1758835919899850. doi: 10.1177/1758835919899850. eCollection 2020
CARDIONCOLOGY.ORG ABSTRACT:
This article evaluates the possibility of using the Khorana Score (KS) as a measure to predict the risk of colorectal cancer (CRC) during chemotherapy.
Findings from 1380 patients suggest that KS is not a predictive factor for either VTE occurrence or overall survival.
© All Rights Reserved